Back to search

Article

The safety and immunogenicity of a combined pertussis containing vaccine Tdap for HIV infected pregnant women and their newborns (WoMANPOWER) – A study protocol for a randomized clinical trial

2022-05-17

Abstract excerpt

<h4>Background: </h4> Globally there are an estimated 24.1 million cases and 160,700 deaths from pertussis annually in children under five years. The disease burden is higher in low- and middle-income countries, especially the African region, which contributes the largest proportions of cases and deaths. Immunization against pertussis in pregnancy is a recommended strategy for the prevention of infant pertussis in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a404c626-18f9-526e-8789-21edf41a1ece
DOI
10.12688/wellcomeopenres.17749.1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The safety and immunogenicity of a combined pertussis containing vaccine Tdap for HIV infected pregnant women and their newborns (WoMANPOWER) – A study protocol for a randomized clinical trialDOI 10.12688/wellcomeopenres.17749.1
Vaccination In Pregnancy Against Pertussis And Seasonal Influenza: Key Learnings And Components From High-Performing Vaccine Programmes In Three Countries: United Kingdom, The United States And SpainSemantic proximity
Gestational pertussis vaccination and the infant’s cellular immune response against whole-cell pertussis vaccine in the first year of lifeSemantic proximity
Safety and implementation of a phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newbornsSemantic proximity
Protection to Six Vaccinable Pathogens in Paired Plasma/DBS and HIV Impact in Infected and Uninfected Children From KinshasaSemantic proximity
Safety and Effectiveness of Maternal COVID-19 Vaccines Among Pregnant People and InfantsSemantic proximity
Early Innate Immune Signatures Imprint Clinical Outcomes of <i>Bordetella pertussis</i> Challenge in a Controlled Human Infection ModelSemantic proximity
Evaluation of PCR methods for the diagnosis of pertussis by the European surveillance network for vaccine-preventable diseases (EUVAC.NET)Semantic proximity
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn (DMID 21-0004)Semantic proximity
T-cell immune responses toBordetella pertussisinfection and vaccination: Graphical Abstract Figure.Semantic proximity
Asymptomatic Bordetella pertussis infections in a longitudinal cohort of young African infants and their mothersSemantic proximity
Mucosal and Systemic Antibodies Associated with Clinical Protection in a Pertussis Controlled Human Infection ModelSemantic proximity
Inequity of antenatal influenza and pertussis vaccine coverage in Australia: The Links2HealthierBubs record linkage cohort study, 2012-2017Semantic proximity
Select a neighboring publication to make it the new centre.